An anti-inflammation injectable drug can reduce mucus buildup and improve breathing among asthma patients, a new clinical trial says. The drug dupilumab (Dupixent) effectively clears up airways plugged by mucus during an asthma attack, researchers reported Oct. 27 in the American Journal of Respiratory and Critical Care Medicine. Results found half as many patients had mucus-plugged airways following treatment with the drug. “In moderate-to-severe asthma, a buildup of mucus in the lungs can obstruct breathing airways to the point where affected patients suffer limited breathing, severe asthma attacks, and even death,” lead researcher Dr. Celeste Porsbjerg said in a news release. She’s a professor of severe asthma at Bispebjerg Hospital in Copenhagen, Denmark. Everyone has some mucus in their system, but it typically isn’t bothersome unless we’re stricken with a cold or the flu, researchers noted. But mucus can be life-threatening to someone with asthma, if inflammation tightens their airway and breathing is cut off by phlegm, researchers said. “For patients who experience increased mucus production with their asthma flares or attacks, it leads to increased stress/distress and anxiety. Sometimes the stuck mucus can cause gagging because it gets stuck and they can’t expel it or cough it out,” De De Gardner, chief research officer for the Allergy & Asthma Network, said in a news release. Gardner was not involved in the study. Dupilumab originally… read on > read on >

















